National Health Investors (NYSE:NHI) Updates FY24 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share guidance of $4.52-4.56 for the period, compared to the consensus earnings per share estimate of $4.41. National Health Investors also updated its FY 2024 guidance to 4.520-4.560 EPS.

National Health Investors Price Performance

NHI traded down $0.15 during trading on Thursday, reaching $74.50. 84,042 shares of the stock were exchanged, compared to its average volume of 165,203. National Health Investors has a 1 year low of $48.51 and a 1 year high of $76.65. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of 24.65 and a beta of 1.02. The business’s 50 day moving average price is $69.76 and its two-hundred day moving average price is $63.24. The company has a debt-to-equity ratio of 0.91, a current ratio of 13.24 and a quick ratio of 13.24.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a net margin of 41.40% and a return on equity of 10.41%. The business had revenue of $84.97 million for the quarter, compared to analysts’ expectations of $64.95 million. During the same quarter last year, the business posted $1.06 earnings per share. The business’s revenue was up 9.1% compared to the same quarter last year. As a group, equities research analysts anticipate that National Health Investors will post 4.4 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, September 27th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.83%. The ex-dividend date is Friday, September 27th. National Health Investors’s payout ratio is 118.03%.

Analysts Set New Price Targets

NHI has been the topic of a number of analyst reports. Wells Fargo & Company increased their price objective on National Health Investors from $63.00 to $69.00 and gave the company an overweight rating in a research note on Thursday, May 30th. StockNews.com lowered shares of National Health Investors from a buy rating to a hold rating in a research report on Thursday, April 18th. Finally, Truist Financial raised their target price on shares of National Health Investors from $58.00 to $65.00 and gave the stock a hold rating in a research report on Wednesday, June 26th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors currently has a consensus rating of Hold and an average target price of $62.13.

Insider Transactions at National Health Investors

In related news, Director Robert A. Mccabe, Jr. purchased 437 shares of the stock in a transaction that occurred on Friday, May 31st. The stock was purchased at an average cost of $65.83 per share, for a total transaction of $28,767.71. Following the acquisition, the director now owns 21,585 shares in the company, valued at $1,420,940.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.26% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.